Rebirth Strongest Tycoon

You can search “Rebirth Strongest Tycoon 妙笔阁novel website (imiaobige.com)” in Baidu to find the latest chapter!

In the evening, Xia Yu convened all members of the acquisition team, summarized today’s results, and agreed on tomorrow’s plan based on the situation.

As soon as you come up, you will first report the status of each group.

Needless to say, Xia Yu won them all on the same day.

Peter Lynch’s 2nd group is in charge of York Capital.

He reported to Xia Yu: “Board-Chairman, today we negotiated with the CEO of York Capital for a day. They have agreed to sell equity shares. The difficulty now is that the price cannot be agreed.”

“York Capital Company bid 5000 5 million USD. Due to time constraints, the negotiation was terminated.”

Xia Yu was slightly nodded and looked towards 3rd Group Leader Brandon Gus. The latter immediately said: “Board-Chairman, Conston Capital has great confidence in Genentech and has refused to sell equity shares until the afternoon, We just persuaded them to agree to sell equity shares, but they offered a high price, 100:8 per 6 equity shares asking for 2 1000 1.5 million USD!”

According to this price, it can be seen that their valuation of Genentech is 2 million USD, which is 500 million USD higher than Coller Perkins’ valuation!

But Xia Yu also expressed understanding, because at first, he predicted that Conston Capital’s attitude towards selling equity shares would be the most negative.

After all, they joined in the third round of financing and defeated a lot of opponents. They are destined to have the most confidence in Genentech.

And the latest entry means that their appetite will be the greatest. They also have the capital strength to take this risk, and they have the strength to wait for GeneTek to go public.

Unlike Coller Perkins, which has weak capital and has never seen the big world, Xia Yu’s higher bid made them obediently surrender.

After signalling Brandon Gus to sit down, Xia Yu said with a smile: “In fact, the situation is pretty good. Although there was no success on the day, both of your groups successfully convinced them to sell equity shares. The difference is only the price.”

“York Capital’s valuation of Genentech is 200 million 20 million USD, while Conston Capital’s valuation is 2:500 200 million USD. I am responsible for the acquisition of Coller Perkins. The valuation is only 1 million USD, and the gap here is really big.”

“But it doesn’t matter. Conston Capital has the lowest share ratio. Even if the valuation is high, there will be an additional 2 million USD. Promise them!”

“You can tell them the price of Coller Perkins today to keep the price down!”

“I have only one request. Tomorrow, the acquisition must be ended. This is the company’s first action. I don’t want accidents! I hope you can perform well!”

Everyone heart shivered with cold, they agreed in unison.

Then, continue to discuss the detailed tackling strategy, and strive to let York Capital and Conston Capital follow the pace of Polaris Capital tomorrow!

……

Early the next morning, Peter Lynch and Brandon Gus and the others set off again.

And Xia Yu brought his subordinates and the others to Genentech.

He did not forget that Professor Herb Boyle wanted to see him.

And the equity shares in the hands of Professor Herb Boyle are also something he covets.

Xia Yu waited in the reception room for less than 5 minutes, and saw an old man wearing glasses and over 50 years old walking in.

Xia Yu saw the photo and immediately recognized that this person is Professor Herb Boyle.

He immediately got up and greeted with respect: “Professor Herb Boyle, hello, I am the Board-Chairman of Polaris Capital, and my name is Xia Yu. You can call me Xia.”

Professor Herb Boyle was not arrogant. He smiled, shook hands with Xia Yu, and called Xia Yu’s name awkwardly, saying, “Hello, Mr. Xia! Please sit down!”

“Thank you, please sit down too!”

After being seated one after another, Professor Herb Boyle asked bluntly: “Mr. Xia, Robert S. 10000 Sen already told me yesterday that their company’s equity shares have been sold to you, and you agreed to me. The conditions, now we are facing each other, I want to know what is the purpose of your acquisition of Genentech? What is your attitude?”

It’s worthy of being a scientific researcher, speaking straight and straight, but this kind of personality is just right, without that many intestines, as long as you touch the right door, you will actually get along well.

Xia Yu said with a smile: “Professor Herb Boyle, the reason why we acquired Genentech is because we are very optimistic about you. We believe that your research can benefit the world, so we are willing to help you transfer your research results Push to the world, and get some compensation in the process by the way.”

Xia Yu’s words are very artistic. Even if Professor Herb Boyle doesn’t like people shooting flattery, the corners of his mouth are raised slightly, his complexion is lightened a lot, and he is much closer to Xia Yu.

Professor Herb Boyle forced a smile and said, “Mr. Xia, if you really have this attitude, then I welcome you!”

Xia Yu was nodded immediately, and the scene was very open: “Of course, we will fully support your research.”

“By the way, Professor Herb Boyle, we are very optimistic about you, so in addition to acquiring the equity shares of Coller Perkins, we are also acquiring the equity shares of York Capital and Conston Capital.”

In a few simple words, Xia Yu already knows what the nature of Professor Herb Boyle is, so in order to avoid misunderstandings, he clarified the matter.

Professor Herb Boyle really didn’t know the news. He was frowned, staring at Xia Yu, and said: “You bought the equity shares of their two companies, then Genentech’s listing process will be terminated, but The production of my research and patents requires a lot of money!”

Xia Yu looked at him calmly and immediately said: “This is not a problem, Professor Herb Boyle, no matter how much money you need, our Polaris Capital can inject capital! As long as you need it!”

After that, in order to dispel Professor Herb Boyle’s doubts, Xia Yu also shifted his mind and said: “Professor Herb Boyle, in fact, you should know that there are advantages to listing companies, but there are also disadvantages. Tektronix has encountered difficulties. The stock market will put tremendous pressure on you, and your plans will be subject to stricter approvals. The spotlight of the media will always shine on you, making you unable to carry out scientific research at ease!”

Xia Yu’s words are very reasonable. Professor Herb Boyle also learned about the advantages and disadvantages of the stock market in his spare time, and he is naturally aware of past cases.

“As far as I know, Genentech went public because the next scientific research and expansion will require a large amount of funds. Now we can afford the money. I hope you can avoid being disturbed by the noisy outside world. We will do our best for you. Create a better scientific research environment.”

Professor Herb Boyle was able to win the Nobel Prize. He was naturally a person who was fascinated by experiments. If the funds required for the next expansion were not too large, the three limelight companies might not be able to afford it, and he would not be encouraged. Promise the company to apply for listing.

Now his scientific research results are only two, and they are still under review, and have not yet been put into production, and risks still exist.

Since Xia Yu’s Polaris Capital is willing to take over, he also hopes that he can continue to study quietly.

As for the fact that his equity shares will be diluted after Polaris Capital injects capital, he does not care, he is not keen on money, and even he has the idea of ​​establishing a scientific research fund after death, as a latecomer in the DNA field. To provide support for research.

His success has a great chance of luck, but not every time a lucky Goddess comes, so he does not hope that latecomers will also struggle to find the truth because of the difficult scientific research conditions.

“Mr. Xia, you are welcome to join!”

Professor Herb Boyle said with a faint smile.

“Professor Herb Boyle, thank you, I believe we will get along very happily in the future!” Xia Yu said with a smile, shaking hands with her again.

Professor Herb Boyle smiled and nodded: “I hope so!”

“Now the company’s funds are not enough. After you finish the acquisition, I hope you can inject funds as soon as possible!”

“No problem, if we can end the acquisition today, then we can inject capital at any time, everything is based on your wishes!”

……

The chat between Xia Yu and Professor Herb Boyle was very pleasant, but the latter was thinking about his experiment. After resolving the doubts in his heart, he said goodbye and hurried back to the laboratory.

In the afternoon, the acquisitions of both groups were completed.

Among them, Peter Lynch took out the case of Coller Perkins. York Capital’s psychological defenses collapsed at once, and finally transferred 5000% of the equity shares he held for 1 25 million USD. .

As for Brandon Gus, he did his best to reduce Genentech’s valuation to 200 million 20 million USD.

Therefore, the 100:8 6 equity shares held by Conston Capital, the transfer price is 1800 9 120,000 USD.

So far, Polaris Capital has spent a total of 200000000 million 1900 9 120,000 USD and acquired 50% of the 8:6 equity shares, becoming the first major shareholder of Genentech.

At this price, Xia Yu is very satisfied.

Because he knows that the capital market is very enthusiastic about Genentech. According to the historical trajectory, on the day of Genentech’s listing, the stock price rose from 35 USD to the highest 88 USD. Even at the closing price, it exceeded 70 USD. The market value is directly It reached 300000000 million USD.

Now it is very worthwhile to cut Husband half a year ahead of schedule and control Genentech’s valuation to just over 200 million USD.

Of course, if you consider Genentech’s future market value of 1000 to 100000000 million, it will be more worthwhile!

After completing the acquisition, Xia Yu immediately approached Professor Herb Boyle to discuss the capital injection.

In order to leave a good impression, Xia Yu was not too harsh, and valued the current Genentech company at 200 million 10 million USD.

And in order to win as many equity shares as possible, Xia Yu, from the perspective of Professor Herb Boyle, continuously encouraged him to develop by leaps and bounds, purchase newer and better experimental instruments, and build a top laboratory. And directly build a large factory.

In short, how to spend money is to take advantage of this rare opportunity to get as much equity shares as possible.

If you don’t seize the opportunity to come fiercely this time, you won’t know the time that will never come next time, and becoming this General by then is extremely scary!

Professor Herb Boyle was coaxed into red light by Xia Yu and felt very good for Xia Yu.

In the end, a huge expansion plan was made, and the negotiation decided to inject 50 million USD into the company at one time!

After the capital injection, Xia Yu’s equity shares increased by 19.2% 3.

The proportion of total shares increased to 70% 7 points 8 3.

On the other hand, the share ratio of Professor Herb Boyle dropped from 40% to 4 to 20%, to 2.

At this step, Xia Yu can officially announce it!

Genentech, the hunt is successful!